240 results on '"P. Ypma"'
Search Results
2. P18 SKIN EXPRESSION OF P16INK4A, A BIOMARKER FOR CELLULAR SENESCENCE, DOES NOT PREDICT FRAILTY OR TREATMENT OUTCOME IN NEWLY DIAGNOSED MULTIPLE MYELOMA
- Author
-
F. Smits, K. Groen, C. Stege, M. Seefat, I. Nijhof, N. van de Donk, P. Ypma, and S. Zweegman
- Subjects
Diseases of the blood and blood-forming organs ,RC633-647.5 - Published
- 2023
- Full Text
- View/download PDF
3. Evidential strength of categorical expert witness statements
- Author
-
Ypma, Rolf JF
- Subjects
Statistics - Applications - Abstract
In many jurisdictions, forensic evidence is presented in the form of categorical statements by forensic experts. Several large-scale performance studies have been performed that report error rates to elucidate the uncertainty associated with such categorical statements. There is growing scientific consensus that the likelihood ratio (LR) framework is the logically correct form of presentation for forensic evidence evaluation. Yet, results from the large-scale performance studies have not been cast in this framework. Here, I show how to straightforwardly calculate an LR for any given categorical statement using data from the performance studies. This number quantifies how much more we should believe the hypothesis of same source vs different source, when provided a particular expert witness statement. LRs are reported for categorical statements resulting from the analysis of latent fingerprints, bloodstain patterns, handwriting, footwear and firearms. The highest LR found for statements of identification was 376 (fingerprints), the lowest found for statements of exclusion was 1/28 (handwriting). The LRs found may be more insightful for those used to this framework than the various error rates reported previously. An additional advantage of using the LR in this way is the relative simplicity; there are no decisions necessary on what error rate to focus on or how to handle inconclusive statements. The values found are closer to 1 than many would have expected. One possible explanation for this mismatch is that we undervalue numerical LRs. Finally, a note of caution: the LR values reported here come from a simple calculation that does not do justice to the nuances of the large-scale studies and their differences to casework, and should be treated as ball-park figures rather than definitive statements on the evidential value of whole forensic scientific fields.
- Published
- 2024
4. Principal Component Copulas for Capital Modelling
- Author
-
Gubbels, K. B., Ypma, J. Y., and Oosterlee, C. W.
- Subjects
Statistics - Methodology ,Economics - Econometrics ,Quantitative Finance - Risk Management - Abstract
We introduce a class of copulas that we call Principal Component Copulas. This class intends to combine the strong points of copula-based techniques with principal component-based models, which results in flexibility when modelling tail dependence along the most important directions in multivariate data. The proposed techniques have conceptual similarities and technical differences with the increasingly popular class of factor copulas. Such copulas can generate complex dependence structures and also perform well in high dimensions. We show that Principal Component Copulas give rise to practical and technical advantages compared to other techniques. We perform a simulation study and apply the copula to multivariate return data. The copula class offers the possibility to avoid the curse of dimensionality when estimating very large copula models and it performs particularly well on aggregate measures of tail risk, which is of importance for capital modeling.
- Published
- 2023
5. Modeling the persistence of 4CMenB vaccine protection against real world meningococcal B disease in adolescents
- Author
-
Argante, Lorenzo, Prunas, Ottavia, Medini, Duccio, and Ypma, Ellen
- Published
- 2024
- Full Text
- View/download PDF
6. Plasma proteomes of acute myeloid leukemia patients treated with transfusions reveal signatures of inflammation and hemostatic dysregulation
- Author
-
Smit, Eva R., Muñoz Sandoval, Diana, Kreft, Iris C., van der Meer, Pieter F., van der Zwaan, Carmen, Voorberg, Jan, Ypma, Paula F., Hoogendijk, Arie J., Kerkhoffs, Jean-Louis, and van den Biggelaar, Maartje
- Published
- 2024
- Full Text
- View/download PDF
7. Modeling the persistence of 4CMenB vaccine protection against real world meningococcal B disease in adolescents
- Author
-
Lorenzo Argante, Ottavia Prunas, Duccio Medini, and Ellen Ypma
- Subjects
Immunologic diseases. Allergy ,RC581-607 ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Abstract The efficacy of the four-component 4CMenB vaccine is measured through the serum bactericidal antibody (SBA) assay on four meningococcal B (MenB) indicator strains. However, they are not epidemiologically relevant for disease, thus the real-world persistence of 4CMenB protection remains uncertain. Several mathematical models of waning immunity were fitted on longitudinal SBA data from persistence studies in adolescents, with up to eight years follow-up after 4CMenB priming vaccination. The best model was used to predict protection from indicator strains. MenB typing data from the United States were used to integrate antigen-level curves and predict the persistence of protection from real-world MenB strains, considering synergies between antigens. Models show that protection and its evolution varied by antigen and that 4CMenB likely elicits antibody-producing long-lived plasma cells. 4CMenB protection from real-world MenB disease persisted at 61.5% four years post-priming and 70.5% four years post-booster. This evidence could support decision-making on adolescent immunization programs.
- Published
- 2024
- Full Text
- View/download PDF
8. Mucositis-associated bloodstream infections in adult haematology patients with fever during neutropenia: risk factors and the impact of mucositis severity
- Author
-
de Jonge, Nick A., Janssen, Jeroen J. W. M., Ypma, Paula, Herbers, Alexandra H. E., de Kreuk, Arne, Vasmel, Wies, van den Ouweland, Jody M. W., Beeker, Aart, Visser, Otto, Zweegman, Sonja, Blijlevens, Nicole M. A., van Agtmael, Michiel A., and Sikkens, Jonne J.
- Published
- 2024
- Full Text
- View/download PDF
9. Field data on sea ice restoration by artificial flooding4TU.ResearchData
- Author
-
Tim C. Hammer, Aleksey Shestov, Laurina Leuntje van Dijke, Fonger Ypma, Tom Meijeraan, and Hayo Hendrikse
- Subjects
Snow ,Albedo ,Snow ice ,Melting ,Radiation ,Computer applications to medicine. Medical informatics ,R858-859.7 ,Science (General) ,Q1-390 - Abstract
A field campaign in the Vallunden lagoon in the Van Mijenfjorden on Spitsbergen was conducted to gather data on sea ice restoration by artificial flooding. Sea ice thickening was initiated by pumping sea water from below the first-year sea ice onto the surface without removing the covering snow layer. Part of the data was collected by four thermistor strings, two radiation sensors, and one anemometer. All measurement systems were left in the field until recovery of the floating systems in summer. Data provided by the measurement devices were received remotely to gather data before, during, and after the flooding phase (including the melting for as long as the sensors were sending data). Furthermore, coring systems were used to extract 88 ice cores for analysis of temperature, density and bulk salinity profiles along the full length of the ice cores before, during and within four days after flooding. The data set can be used to investigate physical processes involved in the ice growth before, during and after flooding. The data can be used to understand the development, growth and melting of snow ice. The radiation data can be used to analyze the (reflected) radiation of the initial, flooded and melting ice. Data gathered during the melting can be used to investigate the melting of thickened sea ice with different initial conditions prior to the onset of melting. Data on bulk salinity can be used to investigate short-term salt migration. Combing the different insights, growth- and melting models of sea ice including snow and snow ice can be validated. The understanding of melt-water drainage events could be improved and flow models for simulation of artificial flooding of snow-covered first-year sea ice could be further developed using the data.
- Published
- 2024
- Full Text
- View/download PDF
10. Bortezomib before and after high‐dose therapy in transplant‐eligible patients with newly diagnosed multiple myeloma: Long‐term overall survival after more than 10 years of follow‐up from the phase III HOVON‐65/GMMG‐HD4 trial
- Author
-
Elias K. Mai, Axel Nogai, Henk M. Lokhorst, Bronno van derHolt, Sonja Zweegman, Katja C. Weisel, Sandra Croockewit, Anna Jauch, Jens Hillengass, Marian Stevens‐Kroef, Marc S. Raab, Annemiek Broijl, Gerard M. J. Bos, Peter Brossart, Paula Ypma, Christine Hanoun, Uta Bertsch, Thomas Hielscher, Hans J. Salwender, Christoph Scheid, Hartmut Goldschmidt, and Pieter Sonneveld
- Subjects
Diseases of the blood and blood-forming organs ,RC633-647.5 - Published
- 2024
- Full Text
- View/download PDF
11. Calculating LRs for presence of body fluids from mRNA assay data in mixtures
- Author
-
Ypma, R. J. F., Wijk, P. A. Maaskant-van, Gill, R. D., Sjerps, M., and Berge, M. van den
- Subjects
Statistics - Applications - Abstract
Messenger RNA (mRNA) profiling can identify body fluids present in a stain, yielding information on what activities could have taken place at a crime scene. To account for uncertainty in such identifications, recent work has focused on devising statistical models to allow for probabilistic statements on the presence of body fluids. A major hurdle for practical adoption is that evidentiary stains are likely to contain more than one body fluid and current models are ill-suited to analyse such mixtures. Here, we construct a likelihood ratio (LR) system that can handle mixtures, considering the hypotheses H1: the sample contains at least one of the body fluids of interest (and possibly other body fluids); H2: the sample contains none of the body fluids of interest (but possibly other body fluids). Thus, the LR-system outputs an LR-value for any combination of mRNA profile and set of body fluids of interest that are given as input. The calculation is based on an augmented dataset obtained by in silico mixing of real single body fluid mRNA profiles. These digital mixtures are used to construct a probabilistic classification method (a 'multi-label classifier'). The probabilities produced are subsequently used to calculate an LR, via calibration. We test a range of different classification methods from the field of machine learning, ways to preprocess the data and multi-label strategies for their performance on in silico mixed test data. Furthermore, we study their robustness to different assumptions on background levels of the body fluids. We find logistic regression works as well as more flexible classifiers, but shows higher robustness and better explainability. We test the system's performance on lab-generated mixture samples, and discuss practical usage in case work., Comment: 24 pages. This is a pre-publication version. Latest version: now in LaTeX after mainly automatic conversion from Word using "pandoc"
- Published
- 2022
- Full Text
- View/download PDF
12. Establishing phone-pair co-usage by comparing mobility patterns
- Author
-
Bosma, Wauter, Dalm, Sander, van Eijk, Erwin, Harchaoui, Rachid el, Rijgersberg, Edwin, Tops, Hannah Tereza, Veenstra, Alle, and Ypma, Rolf
- Subjects
Statistics - Applications ,Computer Science - Artificial Intelligence - Abstract
In forensic investigations it is often of value to establish whether two phones were used by the same person during a given time period. We present a method that uses time and location of cell tower registrations of mobile phones to assess the strength of evidence that any pair of phones were used by the same person. The method is transparent as it uses logistic regression to discriminate between the hypotheses of same and different user, and a standard kernel density estimation to quantify the weight of evidence in terms of a likelihood ratio. We further add to previous theoretical work by training and validating our method on real world data, paving the way for application in practice. The method shows good performance under different modeling choices and robustness under lower quantity or quality of data. We discuss practical usage in court.
- Published
- 2021
- Full Text
- View/download PDF
13. Detecting the most effective cleanup locations using network theory to reduce marine plastic debris: a case study in the Galapagos Marine Reserve
- Author
-
S. L. Ypma, Q. Bohte, A. Forryan, A. C. Naveira Garabato, A. Donnelly, and E. van Sebille
- Subjects
Geography. Anthropology. Recreation ,Environmental sciences ,GE1-350 - Abstract
The Galapagos Marine Reserve was established in 1986 to ensure protection of the islands' unique biodiversity. Unfortunately, the islands are polluted by marine plastic debris and the island authorities face the challenge to effectively remove plastic from its shorelines owing to limited resources. To optimize efforts, we have developed a methodology to identify the most effective cleanup locations on the Galapagos Islands using network theory. A network is constructed from a Lagrangian simulation describing the flow of macroplastic between the various islands within the Galapagos Marine Reserve, where the nodes represent locations along the coastline and the edges the likelihood of plastic leaving one location and beaching at another. We have found four network centralities that provide the best coastline ranking to optimize the cleanup effort based on various impact metrics. Locations with a high retention rate are particularly favorable for cleanup. The results indicate that using the most effective centrality for finding cleanup locations is a good strategy for heavily polluted regions if the distribution of marine plastic debris on the coastlines is unknown and limited cleanup resources are available.
- Published
- 2022
- Full Text
- View/download PDF
14. Using machine learning and beach cleanup data to explain litter quantities along the Dutch North Sea coast
- Author
-
M. L. A. Kaandorp, S. L. Ypma, M. Boonstra, H. A. Dijkstra, and E. van Sebille
- Subjects
Geography. Anthropology. Recreation ,Environmental sciences ,GE1-350 - Abstract
Coastlines potentially harbor a large part of litter entering the oceans, such as plastic waste. The relative importance of the physical processes that influence the beaching of litter is still relatively unknown. Here, we investigate the beaching of litter by analyzing a data set of litter gathered along the Dutch North Sea coast during extensive beach cleanup efforts between the years 2014 and 2019. This data set is unique in the sense that data are gathered consistently over various years by many volunteers (a total of 14 000) on beaches that are quite similar in substrate (sandy). This makes the data set valuable to identify which environmental variables play an important role in the beaching process and to explore the variability of beach litter concentrations. We investigate this by fitting a random forest machine learning regression model to the observed litter concentrations. We find that tides play an especially important role, where an increasing tidal variability and tidal height leads to less litter found on beaches. Relatively straight and exposed coastlines appear to accumulate more litter. The regression model indicates that transport of litter through the marine environment is also important in explaining beach litter variability. By understanding which processes cause the accumulation of litter on the coast, recommendations can be given for more effective removal of litter from the marine environment, such as organizing beach cleanups during low tides at exposed coastlines. We estimate that 16 500–31 200 kg (95 % confidence interval) of litter is located along the 365 km of Dutch North Sea coastline.
- Published
- 2022
- Full Text
- View/download PDF
15. Comparing the Results of Written Testing for Advanced Cardiac Life Support Teaching Using Team-based Learning and the "Flipped Classroom" Strategy.
- Author
-
Langdorf, Mark I, Anderson, Craig L, Navarro, Roman E, Strom, Suzanne, McCoy, C Eric, Youm, Julie, and Ypma-Wong, Mary F
- Subjects
acls ,flipped classroom ,medical education ,team-based learning - Abstract
Objectives We sought to further determine whether cognitive test results changed for advanced cardiac life support (ACLS) taught in the team-based learning/flipped classroom format (TBL/FC) versus a lecture-based (LB) control. Methods We delivered 2010 ACLS to two classes of fourth-year medical students in the TBL/FC format (2015-2016), compared to three classes in the LB format (2012-2014). There were 27.5 hours of instruction for the TBL/FC model (TBL - 10.5 hours, podcasts - nine hours, small-group simulation - eight hours), and 20 hours (lectures - 12 hours, simulation - eight hours) in LB. We taught TBL for 13 cardiac cases while LB had none. Didactic content and seven simulated cases were the same in lecture (2012-2014) or in podcast formats (2015-2016). Testing was the same using 50 multiple-choice (MC) format questions, 20 rhythm-matching questions, and seven fill-in management of simulated cases. Results Some 468 students enrolled in the course 259 (55.4%) in the LB format in 2012-2014, and 209 (44.6%) in the TBL/FC format in 2015-2016. The scores for two out of three tests (MC and fill-in) increased with TBL/FC. Combined, median scores increased from 93.5% (IQR 90.6, 95.4) to 95.1% (92.5, 96.8, p = 0.0001). More students did not pass one of three tests with LB versus TBL/FC (24.7% versus 18.2%), and two or three parts of the test (8.1% versus 4.3%, p = 0.01). On the contrary, 77.5% passed all three with TBL/FC versus 67.2% with LB (change 10.3%, 95% CI 2.2%-18.2%). Conclusion TBL/FC teaching for ACLS improved written test results compared with the LB format.
- Published
- 2018
16. Decrease in early mortality for newly diagnosed multiple myeloma patients in the Netherlands: a population-based study
- Author
-
Mirian Brink, Kaz Groen, Pieter Sonneveld, Monique C. Minnema, Annemiek Broijl, Avinash G. Dinmohamed, Ellen van der Spek, Mark-David Levin, Paula F. Ypma, Esther de Waal, Eduardus F. M. Ward Posthuma, Sonja Zweegman, and Niels W. C. J. van de Donk
- Subjects
Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Abstract Identification of risk factors for early mortality (EM) in multiple myeloma (MM) patients may contribute to different therapeutic approaches in patients at risk for EM. This population-based study aimed to assess trends in EM and risk factors for EM among MM patients diagnosed in the Netherlands. All MM patients, newly diagnosed between 1989 and 2018, were identified in the Netherlands Cancer Registry. Patients were categorized into three calendar periods (1989–1998, 1999–2008, 2009–2018) and into five age groups (≤65, 66–70, 71–75, 76–80, >80 years). EM was defined as death by any cause ≤180 days post-diagnosis. We included 28,328 MM patients (median age 70 years; 55% males). EM decreased from 22% for patients diagnosed in 1989–1998 to 13% for patients diagnosed in 2009–2018 (P 70 years. Therefore, novel strategies should be explored to improve the outcome of patients at risk for EM.
- Published
- 2021
- Full Text
- View/download PDF
17. Carfilzomib, Pomalidomide, and Dexamethasone As Second-line Therapy for Lenalidomide-refractory Multiple Myeloma
- Author
-
Pieter Sonneveld, Sonja Zweegman, Michele Cavo, Kazem Nasserinejad, Annemiek Broijl, Rosella Troia, Ludek Pour, Sandra Croockewit, Paolo Corradini, Francesca Patriarca, Kalung Wu, Jolanda Droogendijk, Gerard Bos, Roman Hajek, Maria Teresa Petrucci, Paula Ypma, Nicholas Zojer, Monique C. Minnema, and Mario Boccadoro
- Subjects
Diseases of the blood and blood-forming organs ,RC633-647.5 - Abstract
This phase 2 trial investigated reinduction with carfilzomib, pomalidomide, and dexamethasone (KPd) and continuous pomalidomide/dexamethasone in patients at first progression during lenalidomide maintenance. The second objective was to evaluate high-dose melphalan with autologous stem cell transplantation (HDM/ASCT) at first progression. Patients were eligible who had progressive disease according to International Myeloma Working Group (IMWG) criteria. Treatment consisted of 8 cycles carfilzomib (20/36 mg/m2), pomalidomide (4 mg) and dexamethasone. Patients without prior transplant received HDM/ASCT. Pomalidomide 4 mg w/o dexamethasone was given until progression. One hundred twelve patients were registered of whom 86 (77%) completed 8 cycles of KPd. Thirty-five (85%) eligible patients received HDM/ASCT. The median time to discontinuation of pomalidomide w/o dexamethasone was 17 months. Best response was 37% ≥ complete response, 75% ≥ very good partial response, 92% ≥ partial response, respectively. At a follow-up of 40 months median PFS was 26 and 32 months for patients who received KPd plus HDM/ASCT and 17 months for patients on KPd (hazard ratio [HR] 0.61, 95% confidence interval [CI] 0.37-1.00, P = 0.051). PFS was better after longer duration of prior lenalidomide (HR 3.56, 95% CI 1.42-8.96, P = 0.035). Median overall survival (OS) was 67 months. KPd-emerging grade 3 and 4 adverse events included hematologic (41%), cardiovascular (6%), respiratory (3%), infections (17%), and neuropathy (2%). KPd followed by continuous pomalidomide is an effective and safe triple drug regimen in second-line for patients previously exposed to bortezomib and/or refractory to lenalidomide.
- Published
- 2022
- Full Text
- View/download PDF
18. Improving the identification of frail elderly newly diagnosed multiple myeloma patients
- Author
-
Stege, Claudia A. M., Nasserinejad, Kazem, Klein, Saskia K., Timmers, Gert-Jan, Hoogendoorn, Mels, Ypma, Paula F., Nijhof, Inger S., Velders, Gerjo A., Strobbe, Leonie, Durdu-Rayman, Nazik, Westerman, Matthijs, Davidis-van Schoonhoven, Marjan A., van Kampen, Roel J. W., Beeker, Aart, Koster, Ad, Dijk, Amanda C., van de Donk, Niels W. C. J., van der Spek, Ellen, Leys, Rineke B. L., Silbermann, Matthijs H., Groen, Kaz, van der Burg-de Graauw, Nicole C. H. P., Sinnige, Harm A. M., van der Hem, Klaas G., Levenga, Henriette, Bilgin, Yavuz M., Sonneveld, Pieter, Levin, Mark-David, and Zweegman, Sonja
- Published
- 2021
- Full Text
- View/download PDF
19. Fusing linguistic and acoustic information for automated forensic speaker comparison.
- Author
-
Sergidou, E.K., Ypma, Rolf, Rohdin, Johan, Worring, Marcel, Geradts, Zeno, and Bosma, Wauter
- Subjects
ARTIFICIAL neural networks ,SUPPORT vector machines ,LINGUISTIC analysis ,COMBINED ratio ,TELEPHONE calls - Abstract
• We supplement acoustic analysis with frequent-word analysis for speaker comparison. • We see improved Cllr across datasets, speaker genders and recording conditions. • We observe that gains are the highest when recording conditions are noisy. Verifying the speaker of a speech fragment can be crucial in attributing a crime to a suspect. The question can be addressed given disputed and reference speech material, adopting the recommended and scientifically accepted likelihood ratio framework for reporting evidential strength in court. In forensic practice, usually, auditory and acoustic analyses are performed to carry out such a verification task considering a diversity of features, such as language competence, pronunciation, or other linguistic features. Automated speaker comparison systems can also be used alongside those manual analyses. State-of-the-art automatic speaker comparison systems are based on deep neural networks that take acoustic features as input. Additional information, though, may be obtained from linguistic analysis. In this paper, we aim to answer if, when and how modern acoustic-based systems can be complemented by an authorship technique based on frequent words, within the likelihood ratio framework. We consider three different approaches to derive a combined likelihood ratio: using a support vector machine algorithm, fitting bivariate normal distributions, and passing the score of the acoustic system as additional input to the frequent-word analysis. We apply our method to the forensically relevant dataset FRIDA and the FISHER corpus, and we explore under which conditions fusion is valuable. We evaluate our results in terms of log likelihood ratio cost ( C llr ) and equal error rate (EER). We show that fusion can be beneficial, especially in the case of intercepted phone calls with noise in the background. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
20. Heavy menstrual bleeding on direct factor Xa inhibitors: Rationale and design of the MEDEA study
- Author
-
Eva N. Hamulyák, Hanke M. G. Wiegers, Luuk J. J. Scheres, Barbara A. Hutten, Maria E. deLange, Anne Timmermans, Peter E. Westerweel, Marten R. Nijziel, Marieke J. H. A. Kruip, Marije ten Wolde, Paula F. Ypma, Frederikus A. Klok, Laurens Nieuwenhuizen, Sanne vanWissen, Marcel M. C. Hovens, Laura M. Faber, Pieter W. Kamphuisen, Harry R. Büller, and Saskia Middeldorp
- Subjects
dabigatran ,factor Xa inhibitors ,menorrhagia ,prospective studies ,tranexamic acid ,Diseases of the blood and blood-forming organs ,RC633-647.5 - Abstract
Abstract Background In premenopausal women, treatment with direct oral factor Xa inhibitors is associated with an increased risk of heavy menstrual bleeding (HMB) compared with vitamin K antagonists (VKA). Treatment with the direct oral thrombin inhibitor dabigatran appears to be associated with a reduced risk of HMB compared with VKA. These findings come from small observational studies or post hoc analyses of trials in which HMB was not a primary outcome. Use of tranexamic acid during the menstrual period may be effective in patients with HMB, but prospective data regarding efficacy and safety in patients on anticoagulant treatment are lacking. Rationale and Design A direct comparison of a factor Xa inhibitor and a thrombin inhibitor with HMB as primary outcome, as well as an evaluation of the effects of adding tranexamic acid in women with anticoagulant‐associated HMB is highly relevant for clinical practice. The MEDEA study is a randomized, open‐label, pragmatic clinical trial to evaluate management strategies in premenopausal women with HMB associated with factor Xa inhibitor therapy. Outcomes Women using factor Xa inhibitors with proven HMB, as assessed by a pictorial blood loss assessment chart (PBAC) score of >150, will be randomized to one of three study arms: (i) switch to dabigatran; (ii) continue factor Xa inhibitor with addition of tranexamic acid during the menstrual period; or (iii) continue factor Xa inhibitor without intervention. The primary outcome is the difference in PBAC score before and after randomization. Here, we present the rationale and highlight several unique features in the design of the study.
- Published
- 2021
- Full Text
- View/download PDF
21. Flipping the advanced cardiac life support classroom with team-based learning: comparison of cognitive testing performance for medical students at the University of California, Irvine, United State
- Author
-
Boysen-Osborn, Megan, Anderson, Craig L, Navarro, Roman, Yanuck, Justin, Strom, Suzanne, McCoy, Christopher E, Youm, Julie, Ypma-Wong, Mary Frances, and Langdorf, Mark I
- Subjects
Education ,Specialist Studies In Education ,Advanced Cardiac Life Support ,California ,Choice Behavior ,Curriculum ,Educational Measurement ,Humans ,Problem-Based Learning ,Simulation Training ,Students ,Medical ,Advanced cardiac life support ,Choice behavior ,Learning ,Students ,United States ,Specialist studies in education - Abstract
PurposeIt aimed to find if written test results improved for advanced cardiac life support (ACLS) taught in flipped classroom/team-based Learning (FC/TBL) vs. lecture-based (LB) control in University of California-Irvine School of Medicine, USA.MethodsMedical students took 2010 ACLS with FC/TBL (2015), compared to 3 classes in LB (2012-14) format. There were 27.5 hours of instruction for FC/TBL model (TBL 10.5, podcasts 9, small-group simulation 8 hours), and 20 (12 lecture, simulation 8 hours) in LB. TBL covered 13 cardiac cases; LB had none. Seven simulation cases and didactic content were the same by lecture (2012-14) or podcast (2015) as was testing: 50 multiple-choice questions (MCQ), 20 rhythm matchings, and 7 fill-in clinical cases.Results354 students took the course (259 [73.1%] in LB in 2012-14, and 95 [26.9%] in FC/TBL in 2015). Two of 3 tests (MCQ and fill-in) improved for FC/TBL. Overall, median scores increased from 93.5% (IQR 90.6, 95.4) to 95.1% (92.8, 96.7, P=0.0001). For the fill-in test: 94.1% for LB (89.6, 97.2) to 96.6% for FC/TBL (92.4, 99.20 P=0.0001). For MC: 88% for LB (84, 92) to 90% for FC/TBL (86, 94, P=0.0002). For the rhythm test: median 100% for both formats. More students failed 1 of 3 tests with LB vs. FC/TBL (24.7% vs. 14.7%), and 2 or 3 components (8.1% vs. 3.2%, P=0.006). Conversely, 82.1% passed all 3 with FC/TBL vs. 67.2% with LB (difference 14.9%, 95% CI 4.8-24.0%).ConclusionA FC/TBL format for ACLS marginally improved written test results.
- Published
- 2016
22. Is pharmacokinetic-guided dosing of desmopressin and von Willebrand factor-containing concentrates in individuals with von Willebrand disease or low von Willebrand factor reliable and feasible? A protocol for a multicentre, non-randomised, open label cohort trial, the OPTI-CLOT: to WiN study
- Author
-
Marjon H Cnossen, Frank W G Leebeek, Ron A A Mathôt, M Coppens, MJHA Kruip, S Polinder, K Fischer, R Liesner, K Fijnvandraat, Laura H Bukkems, PW Collins, P Chowdary, K Meijer, A Janssen, MH Cnossen, Jessica M Heijdra, Wala Al Arashi, Nico C B de Jager, Michael E Cloesmeijer, Christian M Zwaan, FWG Leebeek, RAA Mathôt, RYJ Tamminga, BAP Laros-van Gorkom, P Brons, SEM Schols, FJM van der Meer, HCJ Eikenboom, REG Schutgens, F Heubel-Moenen, L Nieuwenhuizen, P Ypma, MHE Driessens, CM Zwaan, I van Vliet, D Keeling, J Lock, HCAM Hazendonk, I van Moort, T Preijers, JM Heijdra, NCB de Jager, MCHJ Goedhart, LH Bukkems, W Al Arashi, and ME Cloesmeijer
- Subjects
Medicine - Published
- 2022
- Full Text
- View/download PDF
23. Design of a Prospective Study on Pharmacokinetic-Guided Dosing of Prophylactic Factor Replacement in Hemophilia A and B (OPTI-CLOT TARGET Study)
- Author
-
Tine M.H.J. Goedhart, Laura H. Bukkems, Michiel Coppens, Karin J. Fijnvandraat, Saskia E.M. Schols, Roger E.G. Schutgens, Jeroen Eikenboom, Floor C.J.I. Heubel-Moenen, Paula F. Ypma, L. Nieuwenhuizen, K. Meijer, Frank W. G. Leebeek, Ron A.A. Mathôt, and Marjon H. Cnossen
- Subjects
hemophilia ,pharmacokinetics ,factor viii ,factor ix ,prophylaxis ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
In resource-rich countries, almost all severe hemophilia patients receive prophylactic replacement therapy with factor concentrates to prevent spontaneous bleeding in joints and muscles to decrease the development of arthropathy and risk of long-term disability. Pharmacokinetic (PK)-guided dosing can be applied to individualize factor replacement therapy, as interindividual differences in PK parameters influence factor VIII (FVIII) and FIX activity levels. PK-guided dosing may therefore lead to more optimal safeguarding of FVIII/FIX levels during prophylaxis and on demand treatment. The OPTI-CLOT TARGET study is a multicenter, nonrandomized, prospective cohort study that aims to investigate the reliability and feasibility of PK-guided prophylactic dosing of factor concentrates in hemophilia-A and -B patients in daily clinical practice. At least 50 patients of all ages on prophylactic treatment using standard half-life (SHL) and extended half-life (EHL) factor concentrates will be included during 9 months and will receive PK-guided treatment. As primary endpoint, a minimum of four FVIII/FIX levels will be compared with FVIII/FIX levels as predicted by Bayesian forecasting. Secondary endpoints are the association of FVIII and FIX levels with bleeding episodes and physical activity, expectations and experiences, economic analyses, and optimization of population PK models. This study will lead to more insight in the reliability and feasibility of PK-guided dosing in hemophilia patients. Moreover, it will contribute to personalization of treatment by greater knowledge of dosing regimens needed to prevent and treat bleeding in the individual patient and provide evidence to more clearly associate factor activity levels with bleeding risk.
- Published
- 2022
- Full Text
- View/download PDF
24. A strawman with machine learning for a brain: A response to Biedermann (2022) the strange persistence of (source) 'identification' claims in forensic literature
- Author
-
Geoffrey Stewart Morrison, Daniel Ramos, Rolf JF Ypma, Nabanita Basu, Kim de Bie, Ewald Enzinger, Zeno Geradts, Didier Meuwly, David van der Vloed, Peter Vergeer, and Philip Weber
- Subjects
Forensic inference ,Machine learning ,Criminal law and procedure ,K5000-5582 - Abstract
We agree wholeheartedly with Biedermann (2022) FSI Synergy article 100222 in its criticism of research publications that treat forensic inference in source attribution as an “identification” or “individualization” task. We disagree, however, with its criticism of the use of machine learning for forensic inference. The argument it makes is a strawman argument. There is a growing body of literature on the calculation of well-calibrated likelihood ratios using machine-learning methods and relevant data, and on the validation under casework conditions of such machine-learning-based systems.
- Published
- 2022
- Full Text
- View/download PDF
25. Numerical solution of separable nonlinear equations with a singular matrix at the solution
- Author
-
Shen, Yunqiu and Ypma, Tjalling J.
- Published
- 2020
- Full Text
- View/download PDF
26. Decrease in early mortality for newly diagnosed multiple myeloma patients in the Netherlands: a population-based study
- Author
-
Brink, Mirian, Groen, Kaz, Sonneveld, Pieter, Minnema, Monique C., Broijl, Annemiek, Dinmohamed, Avinash G., van der Spek, Ellen, Levin, Mark-David, Ypma, Paula F., de Waal, Esther, Posthuma, Eduardus F. M. Ward, Zweegman, Sonja, and van de Donk, Niels W. C. J.
- Published
- 2021
- Full Text
- View/download PDF
27. P905: IXAZOMIB-THALIDOMIDE-DEXAMETHASONE INDUCTION FOLLOWED BY IXAZOMIB OR PLACEBO MAINTENANCE IN NON-TRANSPLANT ELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS; LONG-TERM RESULTS OF HOVON-126/NMSG 21.13
- Author
-
K. Groen, M. R. Seefat, B. van der Holt, F. H. Schjesvold, C. A. Stege, M.-D. Levin, M. Hansson, R. B. Leys, J. Regelink, A. Waage, D. Szatkowski, P. Axelsson, T. H. Do, A. Svirskaite, E. van der Spek, E. Haukas, D. Knut-Bojanowska, P. F. Ypma, C. Blimark, U.-H. Mellqvist, N. W. van de Donk, P. Sonneveld, A. Klostergaard, A. J. Vangsted, N. Abdilgaard, and S. Zweegman
- Subjects
Diseases of the blood and blood-forming organs ,RC633-647.5 - Published
- 2022
- Full Text
- View/download PDF
28. Tunable Cell-Adhesive Surfaces by Surface-Initiated Photoinduced Electron-Transfer-Reversible Addition–Fragmentation Chain-Transfer Polymerization.
- Author
-
Kuzmyn, Andriy R., Ypma, Tanja G., and Zuilhof, Han
- Published
- 2024
- Full Text
- View/download PDF
29. Whole-brain functional hypoconnectivity as an endophenotype of autism in adolescents
- Author
-
R.L. Moseley, R.J.F. Ypma, R.J. Holt, D. Floris, L.R. Chura, M.D. Spencer, S. Baron-Cohen, J. Suckling, E. Bullmore, and M. Rubinov
- Subjects
Computer applications to medicine. Medical informatics ,R858-859.7 ,Neurology. Diseases of the nervous system ,RC346-429 - Abstract
Endophenotypes are heritable and quantifiable markers that may assist in the identification of the complex genetic underpinnings of psychiatric conditions. Here we examined global hypoconnectivity as an endophenotype of autism spectrum conditions (ASCs). We studied well-matched groups of adolescent males with autism, genetically-related siblings of individuals with autism, and typically-developing control participants. We parcellated the brain into 258 regions and used complex-network analysis to detect a robust hypoconnectivity endophenotype in our participant group. We observed that whole-brain functional connectivity was highest in controls, intermediate in siblings, and lowest in ASC, in task and rest conditions. We identified additional, local endophenotype effects in specific networks including the visual processing and default mode networks. Our analyses are the first to show that whole-brain functional hypoconnectivity is an endophenotype of autism in adolescence, and may thus underlie the heritable similarities seen in adolescents with ASC and their relatives.
- Published
- 2015
- Full Text
- View/download PDF
30. Desmopressin testing in von Willebrand disease: Lowering the burden
- Author
-
Jessica M. Heijdra, Ferdows Atiq, Wala Al Arashi, Quincy Kieboom, Esmee Wuijster, Karina Meijer, Marieke J.H.A. Kruip, Frank W.G. Leebeek, Marjon H. Cnossen, K. Fijnvandraat, R.A.A. Mathôt, S. Polinder, M. Coppens, R.Y.J. Tamminga, K. Meijer, B.A.P. Laros‐van Gorkom, P. Brons, S.E.M. Schols, F.J.M. van der Meer, H.C.J. Eikenboom, R.E.G. Schutgens, K. Fischer, F. Heubel‐Moenen, L. Nieuwenhuizen, P. Ypma, M.H.E. Driessens, C.M. Zwaan, I. van Vliet, P.W. Collins, R. Liesner, P. Chowdary, D. Keeling, J. Lock, H.C.A.M. Hazendonk, I. van Moort, T. Preijers, N.C.B. de Jager, M.C.H.J. Goedhart, L.H. Bukkems, M.E. Cloesmeijer, A. Janssen, Paediatric Haematology, ARD - Amsterdam Reproduction and Development, Pharmacy, AGEM - Amsterdam Gastroenterology Endocrinology Metabolism, Vascular Medicine, ACS - Pulmonary hypertension & thrombosis, ACS - Amsterdam Cardiovascular Sciences, Graduate School, Other Research, Pediatrics, Hematology, Public Health, Erasmus MC other, and Real World Studies in PharmacoEpidemiology, -Genetics, -Economics and -Therapy (PEGET)
- Subjects
desmopressin ,factor VIII ,Hematology ,von Willebrand factor ,humans ,von Willebrand disease - Abstract
Background: Individuals with von Willebrand disease (VWD) require desmopressin testing because of interindividual response differences. However, testing is burdensome, while not all patients may need extensive testing.Objectives: To provide von Willebrand factor (VWF) cutoffs that predict desmopressin nonresponse and thereby identify individuals who do not need extensive testing in a retrospective cohort. We validated these cutoffs in a prospective cohort.Patients and Methods: We included 376 patients (Type 1 VWD with VWF activity [VWF:Act] Results: All individuals with Type 1 VWD and Type 2 VWD, respectively, with baseline VWF:Act 0.34 IU/ml or greater or 0.28 IU/ml or greater were responders. In individuals with T1 VWF:Act ≥0.89 IU/ml (Type 1 VWD) or T1 VWF:Act 1.10 IU/ml or greater (Type 2 VWD), response remained at T4.Conclusion: Desmopressin testing is not needed when lowest historical VWF:Act is 0.30 IU/ml or greater. In patients with Type 1 VWD who require testing, measurements after T1 are often not needed. In patients with Type 2 VWD who require testing, we advise performing T1 and T4 measurements.
- Published
- 2022
31. Statistical Analysis of Tract-Tracing Experiments Demonstrates a Dense, Complex Cortical Network in the Mouse.
- Author
-
Rolf J F Ypma and Edward T Bullmore
- Subjects
Biology (General) ,QH301-705.5 - Abstract
Anatomical tract tracing methods are the gold standard for estimating the weight of axonal connectivity between a pair of pre-defined brain regions. Large studies, comprising hundreds of experiments, have become feasible by automated methods. However, this comes at the cost of positive-mean noise making it difficult to detect weak connections, which are of particular interest as recent high resolution tract-tracing studies of the macaque have identified many more weak connections, adding up to greater connection density of cortical networks, than previously recognized. We propose a statistical framework that estimates connectivity weights and credibility intervals from multiple tract-tracing experiments. We model the observed signal as a log-normal distribution generated by a combination of tracer fluorescence and positive-mean noise, also accounting for injections into multiple regions. Using anterograde viral tract-tracing data provided by the Allen Institute for Brain Sciences, we estimate the connection density of the mouse intra-hemispheric cortical network to be 73% (95% credibility interval (CI): 71%, 75%); higher than previous estimates (40%). Inter-hemispheric density was estimated to be 59% (95% CI: 54%, 62%). The weakest estimable connections (about 6 orders of magnitude weaker than the strongest connections) are likely to represent only one or a few axons. These extremely weak connections are topologically more random and longer distance than the strongest connections, which are topologically more clustered and shorter distance (spatially clustered). Weak links do not substantially contribute to the global topology of a weighted brain graph, but incrementally increased topological integration of a binary graph. The topology of weak anatomical connections in the mouse brain, rigorously estimable down to the biological limit of a single axon between cortical areas in these data, suggests that they might confer functional advantages for integrative information processing and/or they might represent a stochastic factor in the development of the mouse connectome.
- Published
- 2016
- Full Text
- View/download PDF
32. Flipping the advanced cardiac life support classroom with team-based learning: comparison of cognitive testing performance for medical students at the University of California, Irvine, United States
- Author
-
Megan Boysen-Osborn, Craig L. Anderson, Roman Navarro, Justin Yanuck, Suzanne Strom, Christopher E. McCoy, Julie Youm, Mary Frances Ypma-Wong, and Mark I. Langdorf
- Subjects
advanced cardiac life support ,choice behavior ,learning ,students ,united states ,Special aspects of education ,LC8-6691 ,Medicine - Abstract
Purpose: It aimed to find if written test results improved for advanced cardiac life support (ACLS) taught in flipped classroom/team-based Learning (FC/TBL) vs. lecture-based (LB) control in University of California-Irvine School of Medicine, USA. Methods: Medical students took 2010 ACLS with FC/TBL (2015), compared to 3 classes in LB (2012-14) format. There were 27.5 hours of instruction for FC/TBL model (TBL 10.5, podcasts 9, small-group simulation 8 hours), and 20 (12 lecture, simulation 8 hours) in LB. TBL covered 13 cardiac cases; LB had none. Seven simulation cases and didactic content were the same by lecture (2012-14) or podcast (2015) as was testing: 50 multiple-choice questions (MCQ), 20 rhythm matchings, and 7 fill-in clinical cases. Results: 354 students took the course (259 [73.1%] in LB in 2012-14, and 95 [26.9%] in FC/TBL in 2015). Two of 3 tests (MCQ and fill-in) improved for FC/TBL. Overall, median scores increased from 93.5% (IQR 90.6, 95.4) to 95.1% (92.8, 96.7, P=0.0001). For the fill-in test: 94.1% for LB (89.6, 97.2) to 96.6% for FC/TBL (92.4, 99.20 P=0.0001). For MC: 88% for LB (84, 92) to 90% for FC/TBL (86, 94, P=0.0002). For the rhythm test: median 100% for both formats. More students failed 1 of 3 tests with LB vs. FC/TBL (24.7% vs. 14.7%), and 2 or 3 components (8.1% vs. 3.2%, P=0.006). Conversely, 82.1% passed all 3 with FC/TBL vs. 67.2% with LB (difference 14.9%, 95% CI 4.8-24.0%). Conclusion: A FC/TBL format for ACLS marginally improved written test results.
- Published
- 2016
- Full Text
- View/download PDF
33. Bifurcation of solutions of separable parameterized equations into lines
- Author
-
Yun-Qiu Shen and Tjalling J. Ypma
- Subjects
Separable parameterized equations ,bifurcation ,rank deficiency ,Golub-Pereyra variable projection method ,bordered matrix ,singular value decomposition ,Newton's method ,Mathematics ,QA1-939 - Abstract
Many applications give rise to separable parameterized equations of the form $A(y, mu)z+b(y, mu)=0$, where $y in mathbb{R}^n$, $z in mathbb{R}^N$ and the parameter $mu in mathbb{R}$; here $A(y, mu)$ is an $(N+n) imes N$ matrix and $b(y, mu) in mathbb{R}^{N+n}$. Under the assumption that $A(y,mu)$ has full rank we showed in [21] that bifurcation points can be located by solving a reduced equation of the form $f(y, mu)=0$. In this paper we extend that method to the case that $A(y,mu)$ has rank deficiency one at the bifurcation point. At such a point the solution curve $(y,mu,z)$ branches into infinitely many additional solutions, which form a straight line. A numerical method for reducing the problem to a smaller space and locating such a bifurcation point is given. Applications to equilibrium solutions of nonlinear ordinary equations and solutions of discretized partial differential equations are provided.
- Published
- 2010
34. 'Low' LRs obtained from DNA mixtures: On calibration and discrimination performance of probabilistic genotyping software.
- Author
-
McCarthy-Allen, M., Bleka, Ø., Ypma, R., Gill, P., and Benschop, C.
- Subjects
SOFTWARE validation ,MAXIMUM likelihood statistics ,CALIBRATION ,DNA - Abstract
The validity of a probabilistic genotyping (PG) system is typically demonstrated by following international guidelines for the developmental and internal validation of PG software. These guidelines mainly focus on discriminatory power. Very few studies have reported with metrics that depend on calibration of likelihood ratio (LR) systems. In this study, discriminatory power as well as various calibration metrics, such as Empirical Cross-Entropy (ECE) plots, pool adjacent violator (PAV) plots, log likelihood ratio cost (Cllr and Cllr
cal ), fiducial calibration discrepancy plots, and Turing' expectation were examined using the publicly-available PROVEDIt dataset. The aim was to gain deeper insight into the performance of a variety of PG software in the 'lower' LR ranges (∼LR 1–10,000), with focus on DNAStatistX and EuroForMix which use maximum likelihood estimation (MLE). This may be a driving force for the end users to reconsider current LR thresholds for reporting. In previous studies, overstated 'low' LRs were observed for these PG software. However, applying (arbitrarily) high LR thresholds for reporting wastes relevant evidential value. This study demonstrates, based on calibration performance, that previously reported LR thresholds can be lowered or even discarded. Considering LRs >1, there was no evidence for miscalibration performance above LR ∼1000 when using Fst 0.01. Below this LR value, miscalibration was observed. Calibration performance generally improved with the use of Fst 0.03, but the extent of this was dependent on the dataset: results ranged from miscalibration up to LR ∼100 to no evidence of miscalibration alike PG software using different methods to model peak height, HMC and STRmix. This study demonstrates that practitioners using MLE-based models should be careful when low LR ranges are reported, though applying arbitrarily high LR thresholds is discouraged. This study also highlights various calibration metrics that are useful in understanding the performance of a PG system. • Discriminatory power and calibration performance of PG software are evaluated. • The utility of various calibration metrics are explored in 'low' LR ranges. • Focus was on DNAStatistX and EuroForMix software using the MLE method. • Calibration performance was dependent on Fst value and dataset size. • Results suggest reconsideration of lower LR thresholds and cautious reporting of 'low' LRs. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
35. Panorama de la gestión de la calidad académica universitaria
- Author
-
Albert Ypma
- Subjects
Education ,Special aspects of education ,LC8-6691 - Abstract
Practical analysis of the role played by the staff in charge of the university's academic management. Three aspects are covered. First, a strategic view to discuss the Knowledge Society, the profile required of alumni in the work market and the European policy concerning Higher Education. Second, an outlook on quality, based on the management model from the European Foundation of Quality Management and the Deming cycle: planning, doing, measuring and improving. And finally, the stimulating role of academic management in developing an institutional pedagogical model to be applied in study programs, in the different teaching and learning methods, and developing an atmosphere of academic quality. The model is the result of exchanges carried out among coworkers of Universidad Nacional in the workshops organized by the MHO project Developing Institutional Quality , and also through other Dutch experiences.
- Published
- 2004
36. Colorectal cancer screening in patients with inherited bleeding disorders: high cancer detection rate in hemophilia patients
- Author
-
Kempers, Eva K., van Kwawegen, Calvin B., de Meris, Joke, Spaander, Manon C.W., Schols, Saskia E.M., Ypma, Paula F., Heubel-Moenen, Floor C.J.I., van Vulpen, Lize F.D., Coppens, Michiel, van der Bom, Johanna G., Fijnvandraat, Karin, Meijer, Karina, Eikenboom, Jeroen, Gouw, Samantha C., Leebeek, Frank W.G., and Kruip, Marieke J.H.A.
- Abstract
The population-based colorectal cancer (CRC) screening program in individuals aged 55 to 75 years in the Netherlands uses fecal immunochemical testing (FIT), to detect hemoglobin in feces, followed by colonoscopy in individuals with a positive FIT.
- Published
- 2023
- Full Text
- View/download PDF
37. An Efficient Algorithm for the Separable Nonlinear Least Squares Problem
- Author
-
Yunqiu Shen and Tjalling J. Ypma
- Subjects
separable equations ,nonlinear least squares ,full-rank matrices ,QR factorization ,over-determined systems ,Gauss–Newton method ,least squares solutions ,LU factorization ,quadratic convergence ,Industrial engineering. Management engineering ,T55.4-60.8 ,Electronic computers. Computer science ,QA75.5-76.95 - Abstract
The nonlinear least squares problem m i n y , z ∥ A ( y ) z + b ( y ) ∥ , where A ( y ) is a full-rank ( N + ℓ ) × N matrix, y ∈ R n , z ∈ R N and b ( y ) ∈ R N + ℓ with ℓ ≥ n , can be solved by first solving a reduced problem m i n y ∥ f ( y ) ∥ to find the optimal value y * of y, and then solving the resulting linear least squares problem m i n z ∥ A ( y * ) z + b ( y * ) ∥ to find the optimal value z * of z. We have previously justified the use of the reduced function f ( y ) = C T ( y ) b ( y ) , where C ( y ) is a matrix whose columns form an orthonormal basis for the nullspace of A T ( y ) , and presented a quadratically convergent Gauss–Newton type method for solving m i n y ∥ C T ( y ) b ( y ) ∥ based on the use of QR factorization. In this note, we show how LU factorization can replace the QR factorization in those computations, halving the associated computational cost while also providing opportunities to exploit sparsity and thus further enhance computational efficiency.
- Published
- 2017
- Full Text
- View/download PDF
38. Adherence and profile of non-persistence in patients treated for osteoporosis—a large-scale, long-term retrospective study in The Netherlands
- Author
-
Netelenbos, J. C., Geusens, P. P., Ypma, G., and Buijs, S. J. E.
- Published
- 2011
- Full Text
- View/download PDF
39. Finding evidence for local transmission of contagious disease in molecular epidemiological datasets.
- Author
-
Rolf J F Ypma, Tjibbe Donker, W Marijn van Ballegooijen, and Jacco Wallinga
- Subjects
Medicine ,Science - Abstract
Surveillance systems of contagious diseases record information on cases to monitor incidence of disease and to evaluate effectiveness of interventions. These systems focus on a well-defined population; a key question is whether observed cases are infected through local transmission within the population or whether cases are the result of importation of infection into the population. Local spread of infection calls for different intervention measures than importation of infection. Besides standardized information on time of symptom onset and location of cases, pathogen genotyping or sequencing offers essential information to address this question. Here we introduce a method that takes full advantage of both the genetic and epidemiological data to distinguish local transmission from importation of infection, by comparing inter-case distances in temporal, spatial and genetic data. Cases that are part of a local transmission chain will have shorter distances between their geographical locations, shorter durations between their times of symptom onset and shorter genetic distances between their pathogen sequences as compared to cases that are due to importation. In contrast to generic clustering algorithms, the proposed method explicitly accounts for the fact that during local transmission of a contagious disease the cases are caused by other cases. No pathogen-specific assumptions are needed due to the use of ordinal distances, which allow for direct comparison between the disparate data types. Using simulations, we test the performance of the method in identifying local transmission of disease in large datasets, and assess how sensitivity and specificity change with varying size of local transmission chains and varying overall disease incidence.
- Published
- 2013
- Full Text
- View/download PDF
40. Online Personalization of Hearing Instruments
- Author
-
Ypma, Alexander, Geurts, Job, Özer, Serkan, van der Werf, Erik, and de Vries, Bert
- Published
- 2008
- Full Text
- View/download PDF
41. A Simple Identification Proof for a Mixture of Two Univariate Normal Distributions
- Author
-
Meijer, Erik and Ypma, Jelmer Y.
- Published
- 2008
- Full Text
- View/download PDF
42. Eating Disorders: A Personal Story With Implications for Dentists, Educators and Healthcare Professionals
- Author
-
Meredith Ypma, Kenneth R. Etzel, and Michael A. Siegel
- Subjects
Eating Disorders ,Anorexia Nervosa ,Bulimia Nervosa ,Binge Eating ,Body Image ,Medicine (General) ,R5-920 ,Education - Abstract
Abstract This resource is a stand-alone video presentation that can be used in the classroom, small-group sessions, or continuing education courses, or by individuals as an interprofessional means of attaining a better understanding of the psychosocial, physiologic, emotional, and dental clinical management aspects of eating disorders. The video chronicles the experience of a dental student who overcame an eating disorder. The featured speaker (author MY) describes how her eating disorder first “came out” following a biochemistry lecture during her dental education. The faculty member involved (author KRE) was instrumental in helping her cope with the rigors of dental school and was intimately involved in her recovery. This presentation was based on a symposium put on by the authors at a national dental meeting. The audience response was so overwhelming that it was decided to share this story worldwide. The video is approximately 1 hour long. This length makes it an ideal substitute for a classroom lecture. If utilized in a small-group learning environment, the video can be followed by facilitator-led discussion; for such a use, a time period of 90 minutes to 2 hours would be needed. This presentation is the true life story of one of the authors. Its effectiveness is evident in the emotion it creates in the audience.
- Published
- 2011
- Full Text
- View/download PDF
43. Long Term Behaviour of Glare
- Author
-
Borgonje, B. and Ypma, M. S.
- Published
- 2003
- Full Text
- View/download PDF
44. Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study): an open-label, multicentre, randomised, controlled trial
- Author
-
Bistervels, Ingrid M, Buchmüller, Andrea, Wiegers, Hanke M G, Ní Áinle, Fionnuala, Tardy, Bernard, Donnelly, Jennifer, Verhamme, Peter, Jacobsen, Anne F, Hansen, Anette T, Rodger, Marc A, DeSancho, Maria T, Shmakov, Roman G, van Es, Nick, Prins, Martin H, Chauleur, Céline, Middeldorp, Saskia, van den Akker, Eline S, Bekker, Mireille N, van Bemmel, Thomas, Bertoletti, Laurent, Blanc, Julie, Bleker, Suzanne M, Bourtembourg-Matras, Aude, Bretelle, Florence, Byrne, Bridgette, Couturaud, Francis, Delorme, Pierre, Eerenberg, Elise S, Franssen, Maureen TM, Fuglsang, Jens, Ganzevoort, Wessel, Goffinet, François, de Haan-Jebbink, Jiska M, Heidema, Wieteke, Hertzberg, Monique A, Hovens, Marcel MC, Huisman, Menno V, de Jong-Speksnijder, Leonie, Kamphuisen, Pieter-Willem, O'Keeffe, Denis J, Lacut, Karine, Langenveld, Josje, Lunshof, M Simone, Martens, Caroline P, Merah, Adel, Le Moigne, Emmanuelle, Papatsonis, Dimitri NM, Pernod, Gilles, Perrotin, Franck, Peynaud-Debayle, Edith, Pierre, Fabrice, Plu Bureau, Geneviève, Raia-Barjat, Tiphaine, Rijnders, Robbert JP, Rosario, Roger, Ruivard, Marc, Schmidt, Jeannot, Sueters, Marieke, Vanassche, Thomas, Varlet, Marie-Noëlle, Vivanti, Alexandre J, van der Vlist, Matthieu Y, van der Voet, Lucet F, Vollebregt, Karlijn C, de Vries, Johanna IP, de Weerd, Sabina, Westerweel, Peter E, Wijnberger, Lia DE, ten Wolde, Marije, Ypma, Paula F, Zuily-Lamy, Catherine, Zwart, Joost J, Benachi, Alexandra, Beucher, Gaël, Bezanahary, Holy, de Boer, Karin, de Boer, Marjon A., Bousquet, Frantz, Bremer, Henk A., Bressollette, Luc, Brossard, Aurélie, Chau, Cécile, Cleary, Brian, Comte, Fabienne, Corsini, Thomas, Coustel, Anne, Debaveye, Barbara, Desbrière, Raoul, Duvillard, Cécile, Eckman, Astrid, Eikenboom, Jeroen, Elias, Antoine, Faber, Laura M., Ferrari, Emile, Gallot, Denis, Gauchotte, Emilie, Gaugler, Ingrid, Geerlings, Abby E., O'Gorman, Audrey, Grobost, Vincent, de Groot, Pieter-Kees, van der Ham, David P., Hermsen, Brenda, Kamphorst, Kim, Karovitch, Alan, Kleiverda, Gunilla, Kloster, Aiste, Koops, Annemarieke, Krabbendam, Inneke, Kruip, Marieke J.H.A., Kuipers, Saskia, van Laar, Judith, Laneelle, Damien, Lima, Suzanne, MacMahon, Peter, Mandelbrot, Laurent, van Meir, Claudia A., Menez, Caroline, Morssink, Leonard P., Moulin, Nathalie, Mousty, Eve, Muller, Matthieu, Murphy, Lucy, Peerlinck, Kathelijne, O'Reilly, Alma, de Reus, Maartje, Le Roux, Magali Hilmi, Ryan, Kevin, Samren, Bettina, Schippers, Daniela, Schuitemaker, Nico, Schweizer, Chloé, van der Straaten, Hanneke, Tromeur, Cécile, Vanheule, Kristine, Verhagen, Tamara, Visser, Jantien, Watts, Michael, van Wijngaarden, Wim J., Woiski, Mallory, and Zelis, Maartje
- Abstract
Pregnancy-related venous thromboembolism is a leading cause of maternal morbidity and mortality, and thromboprophylaxis is indicated in pregnant and post-partum women with a history of venous thromboembolism. The optimal dose of low-molecular-weight heparin to prevent recurrent venous thromboembolism in pregnancy and the post-partum period is uncertain.
- Published
- 2022
- Full Text
- View/download PDF
45. Online Personalization of Hearing Instruments
- Author
-
Bert de Vries, Erik van der Werf, Serkan Özer, Job Geurts, and Alexander Ypma
- Subjects
Acoustics. Sound ,QC221-246 ,Electronic computers. Computer science ,QA75.5-76.95 - Abstract
Online personalization of hearing instruments refers to learning preferred tuning parameter values from user feedback through a control wheel (or remote control), during normal operation of the hearing aid. We perform hearing aid parameter steering by applying a linear map from acoustic features to tuning parameters. We formulate personalization of the steering parameters as the maximization of an expected utility function. A sparse Bayesian approach is then investigated for its suitability to find efficient feature representations. The feasibility of our approach is demonstrated in an application to online personalization of a noise reduction algorithm. A patient trial indicates that the acoustic features chosen for learning noise control are meaningful, that environmental steering of noise reduction makes sense, and that our personalization algorithm learns proper values for tuning parameters.
- Published
- 2008
- Full Text
- View/download PDF
46. Perioperative pharmacokinetic-guided factor VIII concentrate dosing in haemophilia (OPTI-CLOT trial): an open-label, multicentre, randomised, controlled trial
- Author
-
van Moort, Iris, Preijers, Tim, Bukkems, Laura H, Hazendonk, Hendrika C A M, van der Bom, Johanna G, Laros-van Gorkom, Britta A P, Beckers, Erik A M, Nieuwenhuizen, Laurens, van der Meer, Felix J M, Ypma, Paula, Coppens, Michiel, Fijnvandraat, Karin, Schutgens, Roger E G, Meijer, Karina, Leebeek, Frank W G, Mathôt, Ron A A, Cnossen, Marjon H, Cnossen, Marjon H., Leebeek, Frank W.G., Mathôt, Ron A.A., Fijnvandraat, Karin, Coppens, Michiel, Meijer, Karina, Kruip, Marieke J.H.A., Polinder, Suzanne, Lock, Janske, Hazendonk, Hendrika C.A.M., Van Moort, Iris, Heijdra, Jessica M., Goedhart, Marie C.H.J., Al Arashi, Wala, Preijers, Tim, De Jager, Nico C.B., Bukkems, Laura H., Cloesmeijer, Michael E., Janssen, Alexander, Tamminga, Rienk Y.J., Brons, Paul, Schols, Saskia E.M., Eikenboom, Jeroen C.J., Van der Meer, Felix J.M., Schutgens, Roger E.G., Fischer, Kathelijne, Van Galen, Karin P.M., Beckers, Erik E.A.M., Heubel-Moenen, Floor C.J.I., Nieuwenhuizen, Laurens, Ypma, Paula, Driessens, Mariëtte H.E., Van Vliet, Ineke, Collins, Peter W., Liesner, Ri, Chowdary, Pratima, Millar, Carolyn M., Hart, Dan, and Keeling, David
- Abstract
Dosing of replacement therapy with factor VIII concentrate in patients with haemophilia A in the perioperative setting is challenging. Underdosing and overdosing of factor VIII concentrate should be avoided to minimise risk of perioperative bleeding and treatment costs. We hypothesised that dosing of factor VIII concentrate on the basis of a patient's pharmacokinetic profile instead of bodyweight, which is standard treatment, would reduce factor VIII consumption and improve the accuracy of attained factor VIII levels.
- Published
- 2021
- Full Text
- View/download PDF
47. SYMPHONYconsortium: Orchestrating personalized treatment for patients with bleeding disorders
- Author
-
Cnossen, Marjon H., Moort, Iris, Reitsma, Simone H., Maat, Moniek P. M., Schutgens, Roger E. G., Urbanus, Rolf T., Lingsma, Hester F., Mathot, Ron A. A., Gouw, Samantha C., Meijer, Karina, Bredenoord, Annelien L., Graaf, Rieke, Fijnvandraat, Karin, Meijer, Alexander B., Akker, Emile, Bierings, Ruben, Eikenboom, Jeroen C. J., Biggelaar, Maartje, Haas, Masja, Voorberg, Jan, Leebeek, Frank W. G., Cnossen, Marjon H., Reitsma, Simone H., Haas, Masja, Biggelaar, Maartje, Leebeek, Frank W. G., Voorberg, Jan, Maat, Moniek P. M., Schutgens, Roger E. G., Urbanus, Rolf T., Lingsma, Hester F., Mathot, Ron A. A., Gouw, Samantha C., Meijer, Karina, Bredenoord, Annelien L., Graaf, Rieke, Fijnvandraat, Karin, Meijer, Alexander B., Akker, Emile, Bierings, Ruben, Eikenboom, Jeroen C. J., Moort, Iris, Arisz, Ryanne A., Zivkovic, Minka, Hoorn, E. Shannon, Bukkems, Laura H., Goedhart, Tine M. C. H. J., Romano, Lorenzo G. R., Al Arashi, Wala, Cloesmeijer, Michael E., Janssen, Alexander, Brands, Martijn R., Baas, Lieke, Castillo Alferez, Jessica, Zhang, Huan, Laan, Sebastiaan N. J., Boender, Johan, Bom, Johanna G., Bos, Mettine H. A., Burdorf, Lex, Coppens, Michiel, Driessens, Mariette, Fischer, Kathelijne F., Haverman, Lotte, Hazelzet, Jan A., Huisman, Elise J., Jansen, Natalie, Jong, Sean, Kruip, Marieke, Leeuwen, Nikki, Meer, Felix, Meijer, Stephan, Amstel, Hans Kristian Ploos, Polinder, Suzanne, Schols, Saskia E. M., Wijfjes, Guus, Kluft, Kees, Heerde, Waander L., Goedhart, Geertje, Uyl, Carin, Timp, Jasmijn, Stekelenburg, Anke, Moenen, Floor, Ypma, Paula, Nieuwenhuizen, Laurens, and Plat, Arnoud
- Abstract
Treatment choices for individual patients with an inborn bleeding disorder are increasingly challenging due to increasing options and rising costs for society. We have initiated an integrated interdisciplinary national research program. The SYMPHONY consortium strives to orchestrate personalized treatment in patients with an inborn bleeding disorder, by unraveling the mechanisms behind interindividual variations of bleeding phenotype. The SYMPHONY consortium will investigate patients with an inborn bleeding disorder, both diagnosed and not yet diagnosed. Research questions are categorized under the themes: (1) diagnosis, (2) treatment, and (3) fundamental research, and consist of work packages addressing specific domains. Importantly, collaborations between patients and talented researchers from different areas of expertise promise to augment the impact of the SYMPHONY consortium, leading to unique interactions and intellectual property. SYMPHONY will perform research on all aspects of care, treatment individualization in patients with inborn bleeding disorders, as well as diagnostic innovations and results of molecular genetics and cellular model technology with regard to the hemostatic process. We believe that these research investments will lead to health‐care innovations with long‐term clinical and societal impact. This consortium has been made possible by a governmental, competitive grant from the Netherlands Organization for Scientific Research (NWO) within the framework of the NWA‐ORC Call grant agreement NWA.1160.18.038.
- Published
- 2022
- Full Text
- View/download PDF
48. SYMPHONY consortium: Orchestrating personalized treatment for patients with bleeding disorders
- Author
-
Cnossen, Marjon H., van Moort, Iris, Reitsma, Simone H., de Maat, Moniek P.M., Schutgens, Roger E.G., Urbanus, Rolf T., Lingsma, Hester F., Mathot, Ron A.A., Gouw, Samantha C., Meijer, Karina, Bredenoord, Annelien L., van der Graaf, Rieke, Fijnvandraat, Karin, Meijer, Alexander B., van den Akker, Emile, Bierings, Ruben, Eikenboom, Jeroen C.J., van den Biggelaar, Maartje, de Haas, Masja, Voorberg, Jan, Leebeek, Frank W.G., Cnossen, Marjon H., Reitsma, Simone H., de Haas, Masja, van den Biggelaar, Maartje, Leebeek, Frank W.G., Voorberg, Jan, de Maat, Moniek P.M., Schutgens, Roger E.G., Urbanus, Rolf T., Lingsma, Hester F., Mathot, Ron A.A., Gouw, Samantha C., Meijer, Karina, Bredenoord, Annelien L., van der Graaf, Rieke, Fijnvandraat, Karin, Meijer, Alexander B., van den Akker, Emile, Bierings, Ruben, Eikenboom, Jeroen C.J., van Moort, Iris, Arisz, Ryanne A., Zivkovic, Minka, van Hoorn, E. Shannon, Bukkems, Laura H., Goedhart, Tine M.C.H.J., Romano, Lorenzo G.R., Al Arashi, Wala, Cloesmeijer, Michael E., Janssen, Alexander, Brands, Martijn R., Baas, Lieke, del Castillo Alferez, Jessica, Zhang, Huan, Laan, Sebastiaan N.J., Boender, Johan, van der Bom, Johanna G., Bos, Mettine H.A., Burdorf, Lex, Coppens, Michiel, Driessens, Mariette, Fischer, Kathelijne F., Haverman, Lotte, Hazelzet, Jan A., Huisman, Elise J., Jansen, Natalie, de Jong, Sean, Kruip, Marieke, van Leeuwen, Nikki, van der Meer, Felix, Meijer, Stephan, van Amstel, Hans Kristian Ploos, Polinder, Suzanne, Schols, Saskia E.M., Wijfjes, Guus, Kluft, Kees, van Heerde, Waander L., Goedhart, Geertje, Uyl, Carin, Timp, Jasmijn, Stekelenburg, Anke, Moenen, Floor, Ypma, Paula, Nieuwenhuizen, Laurens, and Plat, Arnoud
- Abstract
Treatment choices for individual patients with an inborn bleeding disorder are increasingly challenging due to increasing options and rising costs for society. We have initiated an integrated interdisciplinary national research program.
- Published
- 2022
- Full Text
- View/download PDF
49. Numerical simulation of flow data over two-dimensional hills
- Author
-
Ying, R., Canuto, V. M., and Ypma, R. M.
- Published
- 1994
- Full Text
- View/download PDF
50. Using previous DNA casework data to aid decision making in the process of DNA profile interpretation.
- Author
-
Benschop, Corina C.G., van Kooten, Charissa, Zandstra, Dion, Sjoukema, Pieterjan, Duijs, Francisca E., van den Berge, Margreet, Schepers, Colin, Mandersloot, Jeroen, and Ypma, Rolf
- Subjects
DNA fingerprinting ,DNA analysis ,DECISION support systems ,DECISION making ,DNA - Abstract
In this study, a DNA decision support tool was developed. With this tool we aim to gain insight in what actions are performed with which (types of) DNA profiles in casework, to improve decision making by DNA experts in future cases. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.